Queens-long Island Renal Institute
Overview
Mission
To assure dialysis patients of the finest quality of care, state-of-the-art technology and uncompromised dignity, in a comfortable setting.
What it reported doing in 2024
Queens-long island renal institute, inc. Is a charitable organization that renders renal replacement therapy services to those in need. The facility is located in new hyde park, New York and provides in-center hemodialysis to patients suffering from end stage renal disease (esrd). Treatments are provided to patients in four different patients' shifts, six days per week. Hemodialysis services are provided to patients by licensed and trained professionals in accordance with all state and federal regulations. The organization will bill medicare, medicaid and other third party payers for services rendered to patients. In 2024 queens-long island renal institute served 324 patients throughout the year.
Operating model
- Revenue model
- Earned-program. 94% of the money available for current operations came from fees and other program revenue.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
Nonprofit profile at a glance
- EIN
- 264827558
- IRS 990 coverage
- 2011–2024
- Forms available
- Form 990 2024
- Location
- New Hyde Park, NY, USA
- Phone
- 7182892600
- Rating
- 70
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Hospitals and Related Primary Medical Care Facilities
Reported finances
- Revenue
- $5,215,297
- Expenses
- $5,681,188
- Assets
- $2,132,342
- Liabilities
- $742,320
Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Few specific pay-setting methods are documented in the filing; unanswered boxes are not proof of absence and expenses are high relative to revenue.
Rating breakdown
- Financial Efficiency: 70
- Transparency & Controls: 65
- Accountability: 91
- Sustainability: 16
- Growth: 80
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 81.4%; rating input score 81
- Program expense ratio: 74.8%; rating input score 75
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
- Pay-setting controls: 0 of 6 controls in place; rating input score 0
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Missing
- Written employment contract: Missing
- Compensation survey or study: Missing
- Board or committee approval: Missing
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
- Governance controls: 7 of 9 controls in place; rating input score 78
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: Fail
- Other executive compensation review process: Fail
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: -8.9%; rating input score 14; 14th percentile among comparable filings
- Total-asset coverage ratio: 0.38; rating input score 12; 12th percentile among comparable filings
- Liabilities to assets ratio: 0.35; rating input score 30; 30th percentile among comparable filings
- Officer compensation ratio: 14.5%; rating input score 19; 19th percentile among comparable filings
Growth
- Program expense growth: 1.7% per year; rating input score 100; 20th percentile among comparable filings
- Revenue growth: 2.5% per year; rating input score 100; 24th percentile among comparable filings
- Asset growth: -1.7% per year; rating input score 0; 8th percentile among comparable filings
Details
- Where the money goes: 81.4% of revenue deployed · 74.8% of spending went to programs
- Governance: 7 of 7 board members independent · 7 of 9 filing controls reported
- Programs: 1 filed program accomplishment · $4.2M in reported program spending
- Leadership: top reported pay $2.3M · 13 people listed · 0 of 6 pay-setting controls reported
- Highest-paid contractors: 4 contractors listed · $814K reported
- Consistency: 31 of 31 current checks pass
- Schedules: 6 filed schedules · includes major donors and executive pay
- Filing history: 13 annual filings from 2011 to 2024
- Contacts: How to reach this organization
- Money network: 4 filed money-flow records
- Related organizations: 5 filed related-organization links
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Transparency & Controls: Pay-setting controls scored 0/100.
- High — Sustainability: Operating margin scored 14/100.
- Review — Accountability: Governance controls: 2 of 9 not reported.
- High — Sustainability: Total-asset coverage ratio scored 12/100.
- High — Growth: Asset growth scored 0/100.
- High — Sustainability: Officer compensation ratio scored 19/100.
- Moderate — Sustainability: Liabilities to assets ratio scored 30/100.
Leadership & pay
13 people listed
Highest reported compensation
- MICHAEL ROSENBLUT (PRESIDENT/CEO): $2,348,571 total reported compensation
- ROBERT WERNER (CFO/EVP FOR OPERATIONS): $1,237,920 total reported compensation
- GERALDINE RAMOS (DIRECTOR OF PATIENT CARE SERVICES): $192,703 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2024.